Dr Batra's® Brings Specialised XOGEN Advance Treatment to UAE, powered with 36 Billion Exosomes for Hair Regrowth
Comunicato Precedente
Comunicato Successivo
Commenting on the launch, Dr. Akshay Batra, Trichologist and Managing Director, Dr Batra's® Healthcare, said:
"At Dr Batra's®, we are committed to bringing the world's latest innovations to our patients across the UAE. Hair loss has over 40 causes, from genetics to lifestyle. XOGEN Advance stands out because it not only delivers faster and more effective results but also addresses the root cause with our unique combination of advanced aesthetics and homeopathy. This ensures safe, long-term relief without compromising patient safety or comfort."
How XOGEN Advance Works
Safe & Side-Effect Free
DHA-approved Korean nano-targeted technology ensures results without the risks of irritation, pain, or surgical side-effects. XOGEN Advance is non-invasive, painless, and dependency-free.
Innovation at Affordable Cost
Comparable hair treatments in the UAE are expensive and less effective. By introducing exosome therapy with its
Best Price Guarantee, Dr Batra's® makes this advanced, 6X more powerful solution accessible, safe, and result-driven.
Launch of XOGEN Advance further strengthens Dr Batra's® global legacy of innovation in hair health.
About Dr Batra's® Healthcare
With over 200 clinics across 7 countries, including India, The UAE, The UK, Malaysia, Thailand, Bangladesh, and Bahrain, Dr Batra's® Healthcare has treated over 1.5 million patients globally. Specializing in Hair, Skin, Allergies, Women & Child Health and Mental Health, the brand is committed to holistic, side-effect-free healthcare.
Photo: https://mma.prnewswire.com/media/2762607/Dr_Batra_s_Healthcare.jpg
Logo: https://mma.prnewswire.com/media/2762606/Dr_Batra_s_Healthcare_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/dr-batras-brings-specialised-xogen-advance-treatment-to-uae-powered-with-36-billion-exosomes-for-hair-regrowth-302546679.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




